Propofol Suppresses Gastric Cancer Progression by Regulating circPDSS1/miR-1324/SOX4 Axis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.2166033538338
   PubMed Web of Science ®Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010. doi:10.1016/S0140-6736(14)62038-925467588
   PubMed Web of Science ®Google Scholar
• Chidambaran V, Costandi A, D’Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs. 2015;29(7):543–563.26290263
   PubMed Web of Science ®Google Scholar
• Vasileiou I, Xanthos T, Koudouna E, et al. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009;605(1–3):1–8. doi:10.1016/j.ejphar.2009.01.00719248246
   PubMed Web of Science ®Google Scholar
• Qi Z, Yuan L, Sun N. Propofol exhibits a tumor-suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA-10b/HOXD10 signaling pathway. Oncol Lett. 2019;18(6):6228–6236.31788099
   PubMed Web of Science ®Google Scholar
• Yang N, Liang Y, Yang P, Yang T, Jiang L. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression. Braz J Med Biol Res. 2017;50(1):e5794. doi:10.1590/1414-431x2016579428076456
   PubMed Web of Science ®Google Scholar
• Yu X, Gao Y, Zhang F. Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR-328 and down-regulating ADAM8. Basic Clin Pharmacol Toxicol. 2019;125(3):271–278. doi:10.1111/bcpt.1322430861616
   PubMed Web of Science ®Google Scholar
• Li Y, Dong W, Yang H, Xiao G. Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3. Biotechnol Lett. 2020;42(3):493–504. doi:10.1007/s10529-019-02787-y31894425
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang Y, Zhu Z, Zheng Y, Song B. Propofol inhibits proliferation, migration and invasion of gastric cancer cells by up-regulating microRNA-195. Int J Biol Macromol. 2018;120(Pt A):975–984. doi:10.1016/j.ijbiomac.2018.08.17330171944
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi:10.1038/nature1192823446348
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. doi:10.1186/s12943-018-0934-630626395
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang T, Xiao J. Circular RNAs: promising biomarkers for human diseases. EBioMedicine. 2018;34:267–274. doi:10.1016/j.ebiom.2018.07.03630078734
   PubMed Web of Science ®Google Scholar
• Sun H, Xi P, Sun Z, et al. Circ-SFMBT2 promotes the proliferation of gastric cancer cells through sponging miR-182-5p to enhance CREB1 expression. Cancer Manag Res. 2018;10:5725–5734. doi:10.2147/CMAR.S17259230510446
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang T, Hu Y, et al. Circ-EIF4G3 promotes the development of gastric cancer by sponging miR-335. Pathol Res Pract. 2019;215(9):152507. doi:10.1016/j.prp.2019.15250731257089
   PubMed Web of Science ®Google Scholar
• Lu J, Wang YH, Huang XY, et al. circ-CEP85L suppresses the proliferation and invasion of gastric cancer by regulating NFKBIA expression via miR-942-5p. J Cell Physiol. 2020;235(9):6287–6299. doi:10.1002/jcp.2955632026471
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Li Y, Huang Y, et al. CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2. J Cell Physiol. 2019;234(7):10458–10469. doi:10.1002/jcp.2771430417526
   PubMed Web of Science ®Google Scholar
• Bach DH, Lee SK, Sood AK. Circular RNAs in cancer. Mol Ther Nucleic Acids. 2019;16:118–129. doi:10.1016/j.omtn.2019.02.00530861414
   PubMedGoogle Scholar
• Panda AC. Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.30259358
   PubMed Web of Science ®Google Scholar
• Gattolliat CH, Uguen A, Pesson M, et al. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer. 2015;51(3):409–420. doi:10.1016/j.ejca.2014.12.00725586944
   PubMed Web of Science ®Google Scholar
• Zhang XY, Xu YY, Chen WY. MicroRNA-1324 inhibits cell proliferative ability and invasiveness by targeting MECP2 in gastric cancer. Eur Rev Med Pharmacol Sci. 2020;24(9):4766–4774.32432740
   PubMed Web of Science ®Google Scholar
• Schepers GE, Teasdale RD, Koopman P. Twenty pairs of SOX: extent, homology, and nomenclature of the mouse and human SOX transcription factor gene families. Dev Cell. 2002;3(2):167–170. doi:10.1016/S1534-5807(02)00223-X12194848
   PubMed Web of Science ®Google Scholar
• Liu P, Ramachandran S, Ali Seyed M, et al. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 2006;66(8):4011–4019. doi:10.1158/0008-5472.CAN-05-305516618720
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang J, Yang X, et al. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro. Prostate Cancer Prostatic Dis. 2013;16(4):301–307. doi:10.1038/pcan.2013.2523917306
   PubMed Web of Science ®Google Scholar
• Wang CY, Hua L, Sun J, et al. MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4. Int J Clin Exp Pathol. 2015;8(11):14013–14020.26823713
   PubMed Web of Science ®Google Scholar
• Ulbrich F, Eisert L, Buerkle H, Goebel U, Schallner N. Propofol, but not ketamine or midazolam, exerts neuroprotection after ischaemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-light-chain-enhancer of activated B-cell signalling: a combined in vitro and animal study. Eur J Anaesthesiol. 2016;33(9):670–680. doi:10.1097/EJA.000000000000044926981881
   PubMed Web of Science ®Google Scholar
• Tian Y, Guo S, Guo Y, Jian L. Anesthetic propofol attenuates apoptosis, aβ accumulation, and inflammation induced by sevoflurane through NF-κb pathway in human neuroglioma cells. Cell Mol Neurobiol. 2015;35(6):891–898. doi:10.1007/s10571-015-0184-825809614
   PubMed Web of Science ®Google Scholar
• Su Z, Hou XK, Wen QP. Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression. Eur J Gynaecol Oncol. 2014;35(6):688–691.25556276
   PubMed Web of Science ®Google Scholar
• Zhu F, Li Q, Yang Y, Wang L, Wang J. Propofol suppresses proliferation, migration, invasion and promotes apoptosis by upregulating microRNA-140-5p in gastric cancer cells. Onco Targets Ther. 2019;12:10129–10138. doi:10.2147/OTT.S22536031819507
   PubMed Web of Science ®Google Scholar
• Yang C, Gao J, Yan N, et al. Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3. Oncol Rep. 2017;37(1):587–593. doi:10.3892/or.2016.521827840947
   PubMed Web of Science ®Google Scholar
• Sui H, Zhu C, Li Z, Yang J. Propofol suppresses gastric cancer tumorigenesis by modulating the circular RNA‑PVT1/miR‑195‑5p/E26 oncogene homolog 1 axis. Oncol Rep. 2020;44(4):1736–1746.32945521
   PubMed Web of Science ®Google Scholar
• Zhao H, Wei H, He J, et al. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer. Cell Cycle. 2020;19(19):2538–2552. doi:10.1080/15384101.2020.181039332857667
   PubMed Web of Science ®Google Scholar
• Fang Q, Yang A, Dong A, Zhao L. circPDSS1 stimulates the development of colorectal cancer via activating the wnt/β-catenin signaling. Onco Targets Ther. 2020;13:6329–6337. doi:10.2147/OTT.S24985332636651
   PubMed Web of Science ®Google Scholar
• Yu Q, Liu P, Han G, Xue X, Ma D. CircRNA circPDSS1 promotes bladder cancer by down-regulating miR-16. Biosci Rep. 2020;40(1):BSR20191961. doi:10.1042/BSR2019196131868205
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature1199323446346
   PubMed Web of Science ®Google Scholar
• Chu YL. Circ_0067934 correlates with poor prognosis and promotes laryngeal squamous cell cancer progression by sponging miR-1324. Eur Rev Med Pharmacol Sci. 2020;24(8):4320–4327.32373969
   PubMed Web of Science ®Google Scholar
• Zhu Q, Lu G, Luo Z, et al. CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun. 2018;497(2):626–632. doi:10.1016/j.bbrc.2018.02.11929458020
   PubMed Web of Science ®Google Scholar
• Vervoort SJ, van Boxtel R, Coffer PJ. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene. 2013;32(29):3397–3409. doi:10.1038/onc.2012.50623246969
   PubMed Web of Science ®Google Scholar
• Mehta GA, Parker JS, Silva GO, Hoadley KA, Perou CM, Gatza ML. Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer. Breast Cancer Res Treat. 2017;162(3):439–450. doi:10.1007/s10549-017-4139-228176176
   PubMed Web of Science ®Google Scholar
• Zhang P, Li J, Song Y, Wang X. MiR-129-5p inhibits proliferation and invasion of chondrosarcoma cells by regulating SOX4/Wnt/β-catenin signaling pathway. Cell Physiol Biochem. 2017;42(1):242–253. doi:10.1159/00047732328535514
   PubMedGoogle Scholar
• Zhang J, Zhang K, Hou Y. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway. Mol Med Rep. 2020;22(2):687–696. doi:10.3892/mmr.2020.1115832468065
   PubMed Web of Science ®Google Scholar
• Pang L, Li B, Zheng B, Niu L, Ge L. miR-138 inhibits gastric cancer growth by suppressing SOX4. Oncol Rep. 2017;38(2):1295–1302. doi:10.3892/or.2017.574528656304
   PubMed Web of Science ®Google Scholar